Logo image of SEQUA.BR

SEQUANA MEDICAL NV (SEQUA.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:SEQUA - BE0974340722 - Common Stock

0.6 EUR
-0.03 (-5.36%)
Last: 1/2/2026, 7:00:00 PM
Fundamental Rating

1

SEQUA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SEQUA have multiple concerns. While showing a medium growth rate, SEQUA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SEQUA has reported negative net income.
SEQUA had a negative operating cash flow in the past year.
SEQUA had negative earnings in each of the past 5 years.
SEQUA had a negative operating cash flow in each of the past 5 years.
SEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFSEQUA.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

SEQUA has a worse Return On Assets (-346.67%) than 93.55% of its industry peers.
Industry RankSector Rank
ROA -346.67%
ROE N/A
ROIC N/A
ROA(3y)-300.31%
ROA(5y)-239.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEQUA.BR Yearly ROA, ROE, ROICSEQUA.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SEQUA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEQUA.BR Yearly Profit, Operating, Gross MarginsSEQUA.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

0

2. Health

2.1 Basic Checks

SEQUA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEQUA has more shares outstanding
Compared to 5 years ago, SEQUA has more shares outstanding
The debt/assets ratio for SEQUA is higher compared to a year ago.
SEQUA.BR Yearly Shares OutstandingSEQUA.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SEQUA.BR Yearly Total Debt VS Total AssetsSEQUA.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

2.2 Solvency

Based on the Altman-Z score of -30.39, we must say that SEQUA is in the distress zone and has some risk of bankruptcy.
SEQUA's Altman-Z score of -30.39 is on the low side compared to the rest of the industry. SEQUA is outperformed by 90.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.39
ROIC/WACCN/A
WACC5.6%
SEQUA.BR Yearly LT Debt VS Equity VS FCFSEQUA.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

SEQUA has a Current Ratio of 0.21. This is a bad value and indicates that SEQUA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.21, SEQUA is not doing good in the industry: 93.55% of the companies in the same industry are doing better.
SEQUA has a Quick Ratio of 0.21. This is a bad value and indicates that SEQUA is not financially healthy enough and could expect problems in meeting its short term obligations.
SEQUA's Quick ratio of 0.16 is on the low side compared to the rest of the industry. SEQUA is outperformed by 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.16
SEQUA.BR Yearly Current Assets VS Current LiabilitesSEQUA.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for SEQUA have decreased strongly by -31.91% in the last year.
SEQUA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
SEQUA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -35.84% yearly.
EPS 1Y (TTM)-31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.9%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 26.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, SEQUA will show a very strong growth in Revenue. The Revenue will grow by 462.98% on average per year.
EPS Next Y81.63%
EPS Next 2Y32.86%
EPS Next 3Y26.42%
EPS Next 5YN/A
Revenue Next Year782.35%
Revenue Next 2Y689.05%
Revenue Next 3Y462.98%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SEQUA.BR Yearly Revenue VS EstimatesSEQUA.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
SEQUA.BR Yearly EPS VS EstimatesSEQUA.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEQUA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEQUA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEQUA.BR Price Earnings VS Forward Price EarningsSEQUA.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEQUA.BR Per share dataSEQUA.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

SEQUA's earnings are expected to grow with 26.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.86%
EPS Next 3Y26.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SEQUA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SEQUANA MEDICAL NV

EBR:SEQUA (1/2/2026, 7:00:00 PM)

0.6

-0.03 (-5.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-04 2025-09-04
Earnings (Next)N/A N/A
Inst Owners33.96%
Inst Owner ChangeN/A
Ins Owners4.73%
Ins Owner ChangeN/A
Market Cap40.85M
Revenue(TTM)N/A
Net Income(TTM)-52.00M
Analysts84
Price Target2.79 (365%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.91%
PT rev (3m)-21.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)47.06%
EPS NY rev (3m)70.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)12.5%
Revenue NY rev (3m)8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0
BVpS-0.57
TBVpS-0.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -346.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-300.31%
ROA(5y)-239.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.16
Altman-Z -30.39
F-Score2
WACC5.6%
ROIC/WACCN/A
Cap/Depr(3y)113.65%
Cap/Depr(5y)93.14%
Cap/Sales(3y)89.27%
Cap/Sales(5y)74.02%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.9%
EPS Next Y81.63%
EPS Next 2Y32.86%
EPS Next 3Y26.42%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-34.21%
Revenue growth 5Y-35.84%
Sales Q2Q%-100%
Revenue Next Year782.35%
Revenue Next 2Y689.05%
Revenue Next 3Y462.98%
Revenue Next 5YN/A
EBIT growth 1Y23.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.37%
EBIT Next 3Y-3.53%
EBIT Next 5YN/A
FCF growth 1Y40.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.58%
OCF growth 3YN/A
OCF growth 5YN/A

SEQUANA MEDICAL NV / SEQUA.BR FAQ

What is the fundamental rating for SEQUA stock?

ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR.


What is the valuation status for SEQUA stock?

ChartMill assigns a valuation rating of 1 / 10 to SEQUANA MEDICAL NV (SEQUA.BR). This can be considered as Overvalued.


How profitable is SEQUANA MEDICAL NV (SEQUA.BR) stock?

SEQUANA MEDICAL NV (SEQUA.BR) has a profitability rating of 0 / 10.